Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
![Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society](https://openres.ersjournals.com/content/erjor/4/2/00028-2018/F1.large.jpg)
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society
![JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm? JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?](https://www.mdpi.com/jcm/jcm-08-01217/article_deploy/html/images/jcm-08-01217-g001.png)
JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?
![Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13613-020-00775-4/MediaObjects/13613_2020_775_Fig1_HTML.png)
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text
![Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-021-03571-z/MediaObjects/13054_2021_3571_Fig1_HTML.png)
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text
![International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society](https://erj.ersjournals.com/content/erj/50/3/1700582/F2.large.jpg)
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society
Missouri Society of Health-System Pharmacists - Diagnosis and Treatment of Adults with Community-acquired Pneumonia: 2019 Clinical Practice Guidelines
![JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML](https://www.mdpi.com/jcm/jcm-09-00275/article_deploy/html/images/jcm-09-00275-g001.png)
JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML
![Molecular Profiling of Innate Immune Response Mechanisms in Ventilator-associated Pneumonia - Molecular & Cellular Proteomics Molecular Profiling of Innate Immune Response Mechanisms in Ventilator-associated Pneumonia - Molecular & Cellular Proteomics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bc86895e-6298-480f-ba70-757c90dc99d7/gr8_lrg.jpg)
Molecular Profiling of Innate Immune Response Mechanisms in Ventilator-associated Pneumonia - Molecular & Cellular Proteomics
![The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care](https://rc.rcjournal.com/content/respcare/60/10/1495/F3.large.jpg)
The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care
![Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention | Clinical Microbiology Reviews Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention | Clinical Microbiology Reviews](https://journals.asm.org/cms/10.1128/CMR.00051-05/asset/e2551f95-bc72-41b0-a5cd-5f77526025a2/assets/graphic/zcm0040621900003.jpeg)
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention | Clinical Microbiology Reviews
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
![Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-08307-9/MediaObjects/41598_2022_8307_Fig1_HTML.png)